Market Research Logo

Drug Testing: Technologies and Global Markets

Drug Testing: Technologies and Global Markets

The global drug of abuse (DOA) testing market reached nearly $3.0 billion in 2016. This market is estimated to grow at a compound annual growth rate (CAGR) of 4.5% to reach nearly $3.9 billion by 2022 from $3.1 billion in 2017.

Report Includes
An overview of the global market for drug testing technologies.
Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
An overview of drug abuse trends in terms of various geographic regions as well as drug classes.
Information on leading players in the market and their key products.
Analysis of leading companies in the field and their successful strategies.

Report Scope
This report contains:
An overview of drug abuse trends in terms of various geographic regions as well as drug classes.
Drug abuse statistics in key regions.
Analysis of regulatory environments in North, South and Central America, Europe, and Asia-Pacific, and country-wise summaries of national legislation and policies.
Drug of abuse testing markets with respect to testing approaches and sample matrices.
Technology trends in the drug of abuse testing market.
Leading players in the market and their key products.
Sales projections through 2022 for drug of abuse testing markets by sample matrix and geographic regions.
Analysis of leading companies and their successful strategies.


Chapter 1: Introduction
Study Goals and Objectives
Reasons for Doing the Study
Intended Audience
Scope of Report
Methodology
Information Sources
Geographic Breakdown
Analyst’s Credentials
Related BCC Research Reports
Executive Summary
Chapter 3: Market and Technology Background
Single- Vs. Multi-Parameter Test
DOA Screening
Confirmation Testing
Urine Tests
Other Testing Methods
Blood Testing
Oral Fluid Testing
Saliva Testing
Sweat Testing
Hair Testing
Testing Locations
Laboratory-Based DAT
Point of Care DATS
Onsite Testing Vs Laboratory Testing
Sample Types for Laboratory Testing
Urine Testing
Hair Testing
Saliva/Oral Fluid Testing
Blood Testing
Sweat Testing
Eye Reflex
Detection Period
Fooling a Drug Test
Fooling Urine Testing
Fooling Hair Testing
Fooling Saliva Testing
Sample Validity Tests
False Positives and False Negatives
False Positives
False Negatives
Drug Clearance and Testing Window
Testing Technologies
Immunoassays
Enzyme Immunoassay (EIA)
Enzyme-Linked Immunosorbent Assay (ELISA)
Enzyme Multiplied Immunoassay Technology (EMIT)
Fluorescence Polarization Immunoassay (FPIA)
Radioimmunoassay (RIA)
Chromatography
Eye Reflex Measurements
Chapter 4: Government Regulations: Drug Trafficking and Drug Abuse Testing .. 35
North America
Canada
Mexico
U.S.
State Marijuana Legalization
U.S. Department of Transportation
Drug Testing in the Military
Drug Testing for Welfare Recipients and Public Assistance
Drug Testing for Individuals Convicted of Drug Felonies
South America
Bolivia
Brazil
Colombia
Ecuador
Guyana
Paraguay
Peru
Central America and the Caribbean
Costa Rica
Cuba
El Salvador
Guatemala
Haiti
Jamaica
Nicaragua
Panama
Honduras
The Bahamas
The Netherlands Antilles
Trinidad and Tobago
Europe
Bosnia and Herzegovina
Denmark
France
Germany
Italy
Latvia
Norway
Romania
Sweden
Switzerland
The Netherlands
The United Kingdom
Asia-Pacific
Australia
Bangladesh
Bhutan
Cambodia
Hong Kong
India
Japan
Maldives
Myanmar
Nepal
New Zealand
Singapore
South Korea
Sri Lanka
Taiwan
Thailand
Vietnam
Chapter 5: Overview of Drug Abuse Testing
Drug Abuse Testing
International Drug Trafficking and Illicit Drug Use Trends by Drug Type
Amphetamine-Type Stimulants Market
Cannabis Market
Coca/Cocaine Market
Opium/Heroin Market
International Drug Trafficking and Illicit Drug Use Trends by Geographic Region
Africa
Central America and Caribbean
North America
South America
East and Southeast Asia
South Asia
West Asia
Europe
Oceania
U.S. DOA Statistics
National Household Survey on Drug Abuse: SAMHSA U.S.
Chapter 6: Global Drugs of Abuse Testing Market by Sample Type
DOA Testing Sales
Global Sales of DOA Testing by Urine
Global Sales of DOA Testing by Blood
Global Sales of DOA Testing by Oral Fluid
Global Sales of DOA Testing by Hair
Global Sales of DOA Testing by Sweat
Global Sales of DOA Testing by Other Sample Types
Chapter 7: Global Industry Structure
Regional Analysis
Total DOA Testing and Drug Monitoring Markets and Forecasts
Growth Trends—Laboratory-based and Onsite DOA Testing Markets
Competitive Analysis
Key Market Players in the DOA Testing Markets and Their Products
Laboratory-based DOA Testing Market Segment
Onsite Testing Market Segment for DOA
Common DOA and Most Popular Devices Used for Testing Them
Companies in the Oral Fluid, Hair and Sweat Testing Segments for DOA
Chapter 8: Patent Analysis
Chapter 9: Company Profiles
About BCC Research
About BCC Research
BCC Library Access
BCC Custom Research
List of Tables
Summary Table: Global DOA Testing Market Forecast, by Test Type, Through 2022 ($ Millions)
Table 1 Advantages and Disadvantages of Point of Care Testing
Table 2 Major Advantages and Disadvantages of Onsite Testing
Table 3 Detection Periods for Various Types of Drug Testing
Table 4 Common Parameters Tested for Urine Specimen Validity
Table 5 Some of the Commercial/Common Adulterants Used in Fooling Urine Tests and Their Effects
Table 6 Urine Sample Validity Test Methods
Table 7 Cross Reactants That Can Lead to False Positives in DOA Testing
Table 8 Clearance Rates for Common DOA
Table 9 U.S. Drug Testing Legislations by State, 2017
Table 10 Selected State Marijuana Legalization, 2016
Table 11 Drug Testing Legislation by European Country
Table 12 Number of Illicit Drug Users Globally, 2015 (Millions)
Table 13 Number of Drug-Related Deaths, Mortality Rates per Million Persons Aged 15-64 Years and Ranking of Drugs as Primary Cause of Death (2014 or Latest Year Available), 2016
Table 14 Estimated Number of Drug-Related Deaths and Mortality Rates per Million Persons Aged 15-64 Years, 2014
Table 15 Annual Prevalence by Region, 2016
Table 16 U.S. DOA Seizures, 2014
Table 17 Annual Prevalence of Opioid Use as a Percentage of the Population Aged 15-64, 2015 (%)
Table 18 Annual Prevalence of Cocaine Use as a Percentage of the Population Aged 15-64, 2015 (%) .. 86
Table 19 Annual Prevalence of Cannabis Use as a Percentage of the Population Aged 15-64, 2015 (%) 87
Table 20 Annual Prevalence of ATS Use as a Percentage of the Population Aged 15-64, 2015 (%)
Table 21 Annual Prevalence of Ecstasy Use as a Percentage of the Population Aged 15-64, 2015 (%) ... 90
Table 22 Drug Abuse Statistics in the U.S. by Drug Type (12 Yrs and Older), 2014 and 2015 (Thousands)
Table 23 U.S. Types of Illicit Drug Use in Lifetime, Past Year, and Past Month Among Persons Aged 18 or Older: Percentages, 2014 and 2015 (%)
Table 24 U.S. Illicit Drug Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Percentages, 2014 and 2015 (%)
Table 25 U.S. Marijuana Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Percentages, 2014 and 2015 (%)
Table 26 Global Sales Contribution for DOA Testing, by Sample Type, Through 2022 (%)
Table 27 Global Sales Forecast for DOA Testing, by Sample Type, Through 2022 ($ Millions)
Table 28 Global Sales Forecast for DOA Testing by Urine, Through 2022 ($ Millions)
Table 29 Global Sales Forecast for DOA Testing by Urine: Laboratory-based versus Onsite, through 2022 ($ Millions)
Table 30 Global Sales Forecast for DOA Testing, by Blood, Through 2022 ($ Millions)
Table 31 Global Sales Forecast for DOA Testing, by Oral Fluid, Through 2022 ($ Millions)
Table 32 Global Sales Forecast for DOA Testing by Oral Fluid: Laboratory-based versus Onsite, Through 2022 ($ Millions)
Table 33 Global Sales Forecast for DOA Testing, by Hair, Through 2022 ($ Millions)
Table 34 Global Sales Forecast for DOA Testing, by Sweat, Through 2022 ($ Millions)
Table 35 Global Sales Forecast for DOA Testing, by Other Sample Types, Through 2022 ($ Millions)
Table 36 Global DOA Testing Market Forecast, by Region, Through 2022 ($ Millions)
Table 37 DOA Testing Market Forecast for Laboratory-based DOA Testing, Through 2022 ($ Millions)108
Table 38 DOA Testing Market Forecast for Onsite DOA Testing, Through 2022 ($ Millions)
Table 39 Most Notable Mergers and Acquisitions in the DOA Testing Markets, 2000–2016
Table 40 Major Companies and Their Products in the DOA Testing Market
Table 41 Companies Offering Laboratory-based DOA Testing Products
Table 42 Main Onsite DOA Testing Market Players and Their Products
Table 43 Common DOA and Popular Urine Drug Screening Products
Table 44 Key Market Players Offering DOA Testing Products on Oral Fluid, Hair and Sweat Sample Types
Table 45 Selected U.S. Patents Granted for DOA Testing, 2007-2017
List of Figures
Summary Figure: Global Drugs of Abuse Testing Market Forecast, by Test Matrix, 2016-2022 ($ Millions)
Figure 1 U.S. DOA Seizures, 2014
Figure 2 Global Sales Forecast for DOA Testing, by Sample Type, 2016-2022 ($ Millions)
Figure 3 Global Sales Forecast for Drugs of Abuse Testing by Urine, 2016-2022 ($ Millions)
Figure 4 Global Sales Forecast for Drugs of Abuse Testing by Urine: Laboratory-based versus Onsite, 2016-2022 ($ Millions)
Figure 5 Global Sales Forecast for Drugs of Abuse Testing, by Blood, 2016-2022 ($ Millions)
Figure 6 Global Sales Forecast for Drugs of Abuse Testing, by Oral Fluid, 2016-2022 ($ Millions)
Figure 7 Global Sales Forecast for Drugs of Abuse Testing, by Oral Fluid: Laboratory-based versus Onsite, 2016-2022 ($ Millions)
Figure 8 Global Sales Forecast for Drugs of Abuse Testing, by Hair, 2016-2022 ($ Millions)
Figure 9 Global Sales Forecast for Drugs of Abuse Testing by Sweat, 2016-2022 ($ Millions)
Figure 10 Global Sales Forecast for DOA Testing, by Other Sample Types, 2016-2022 ($ Millions)
Figure 11 Drugs of Abuse Testing Markets, by Geographic Region, 2017 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report